NEW DELHI, Oct 31: Biotechnology major Biocon today posted 4.6 per cent jump in its consolidated net profit to Rs 89.65 crore for the second quarter ended September 30, 2012.
The company had posted a net profit of Rs 85.70 crore in the same period of previous fiscal, Biocon said in a filing to the BSE.
The net sales of the company rose to Rs 592.40 crore for the second quarter from Rs 505.39 crore in the same period of 2011-12 fiscal.
The Bangalore-headquartered firm said GE Equity International Mauritius, a subsidiary of GE Capital, will make a private equity investment in Syngene International to the tune of Rs 125 crore, for a 7.69 per cent equity share.
Syngene International is the research services arm of Biocon. (PTI)
Trending Now
E-Paper
Follow our WhatsApp channel